{"created":"2023-07-27T06:53:38.656233+00:00","id":48441,"links":{},"metadata":{"_buckets":{"deposit":"1035f013-77da-4209-860e-130df4c10edf"},"_deposit":{"created_by":18,"id":"48441","owners":[18],"pid":{"revision_id":0,"type":"depid","value":"48441"},"status":"published"},"_oai":{"id":"oai:kanazawa-u.repo.nii.ac.jp:00048441","sets":["2812:2813:2815"]},"author_link":["584","86269"],"item_9_biblio_info_8":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2019-06-17","bibliographicIssueDateType":"Issued"},"bibliographicPageStart":"6p.","bibliographicVolumeNumber":"2016-04-01 - 2019-03-31","bibliographic_titles":[{"bibliographic_title":"平成30(2018)年度 科学研究費補助金 基盤研究(C) 研究成果報告書"},{"bibliographic_title":"2018 Fiscal Year Final Research Report","bibliographic_titleLang":"en"}]}]},"item_9_creator_33":{"attribute_name":"著者別表示","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{}],"nameIdentifiers":[{},{}]}]},"item_9_description_21":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"急性骨髄性の治療に関して全国より登録された3つのデータベースを解析した。治療関連骨髄性腫瘍は急性骨髄性白血病の5.1～8.1％に認められた。発症年齢は、治療関連骨髄性腫瘍でやや高い傾向が認められ、男女差はなかった。染色体核型は、予後不良を示す者が多い。5年生存率は関連骨髄性腫瘍が有意に悪く、20％以下であるが、症例を選択し有効な治療が行われれば改善する可能性が示唆された。","subitem_description_type":"Abstract"},{"subitem_description":"We analyzed 3 databases of acute myeloid leukemia (AML) that was registered from all of the country. Frequency of therapy-related myeloid neoplasms(t-MN) was between 5.1 and 8.1%. Patients with t-MN were older than patients with de novo AML, and sex difference was not observed. Adverse cytogenetics were observed most frequently in patients with t-MN. Five years survival rate in patients with t-MN was significantly inferior to patients with de novo AML and was less than 20%. Survival probability in patients with t-MN might improve if they could receive intensive treatment.","subitem_description_type":"Abstract"}]},"item_9_description_22":{"attribute_name":"内容記述","attribute_value_mlt":[{"subitem_description":"研究課題/領域番号:16K09843, 研究期間(年度):2016-04-01 - 2019-03-31","subitem_description_type":"Other"},{"subitem_description":"出典：研究課題「治療関連骨髄性腫瘍の疫学的、分子生物学的研究」課題番号16K09843\n（KAKEN：科学研究費助成事業データベース（国立情報学研究所）） \n（https://kaken.nii.ac.jp/report/KAKENHI-PROJECT-16K09843/16K09843seika/）を加工して作成","subitem_description_type":"Other"}]},"item_9_identifier_registration":{"attribute_name":"ID登録","attribute_value_mlt":[{"subitem_identifier_reg_text":"10.24517/00054763","subitem_identifier_reg_type":"JaLC"}]},"item_9_publisher_17":{"attribute_name":"公開者","attribute_value_mlt":[{"subitem_publisher":"金沢大学医薬保健研究域保健学系"}]},"item_9_relation_28":{"attribute_name":"関連URI","attribute_value_mlt":[{"subitem_relation_name":[{"subitem_relation_name_text":"https://kaken.nii.ac.jp/search/?qm=00160523"}],"subitem_relation_type_id":{"subitem_relation_type_id_text":"https://kaken.nii.ac.jp/search/?qm=00160523","subitem_relation_type_select":"URI"}},{"subitem_relation_name":[{"subitem_relation_name_text":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-16K09843/"}],"subitem_relation_type_id":{"subitem_relation_type_id_text":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-16K09843/","subitem_relation_type_select":"URI"}},{"subitem_relation_name":[{"subitem_relation_name_text":"https://kaken.nii.ac.jp/report/KAKENHI-PROJECT-16K09843/16K09843seika/"}],"subitem_relation_type_id":{"subitem_relation_type_id_text":"https://kaken.nii.ac.jp/report/KAKENHI-PROJECT-16K09843/16K09843seika/","subitem_relation_type_select":"URI"}}]},"item_9_version_type_25":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_ab4af688f83e57aa","subitem_version_type":"AM"}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2020-04-24"}],"displaytype":"detail","filename":"ME-PR-OHTAKE-S-kaken 2019-6p.pdf","filesize":[{"value":"194.9 kB"}],"format":"application/pdf","licensetype":"license_11","mimetype":"application/pdf","url":{"label":"ME-PR-OHTAKE-S-kaken 2019-6p.pdf","url":"https://kanazawa-u.repo.nii.ac.jp/record/48441/files/ME-PR-OHTAKE-S-kaken 2019-6p.pdf"},"version_id":"b6731876-e7ca-425e-91c6-1a3a62dc6a45"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"research report","resourceuri":"http://purl.org/coar/resource_type/c_18ws"}]},"item_title":"治療関連骨髄性腫瘍の疫学的、分子生物学的研究","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"治療関連骨髄性腫瘍の疫学的、分子生物学的研究"},{"subitem_title":"Epidemiological and molecular biological study of therapy-related myeloid neoplasms","subitem_title_language":"en"}]},"item_type_id":"9","owner":"18","path":["2815"],"pubdate":{"attribute_name":"公開日","attribute_value":"2020-04-24"},"publish_date":"2020-04-24","publish_status":"0","recid":"48441","relation_version_is_last":true,"title":["治療関連骨髄性腫瘍の疫学的、分子生物学的研究"],"weko_creator_id":"18","weko_shared_id":-1},"updated":"2023-07-27T13:35:10.775069+00:00"}